Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Status:	Completed
Conditions:	High Blood Pressure (Hypertension), Ocular
Therapuetic Areas:	Cardiology / Vascular Diseases, Ophthalmology
Healthy:	No
Age Range:	18 - Any
Updated:	10/14/2017
Start Date:	March 2008
End Date:	October 2008

A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

To investigate the dose-response relationship of DE-104 ophthalmic solution in lowering
intraocular pressure (IOP) in subjects with Primary Open-Angle Glaucoma or Ocular
Hypertension

Inclusion Criteria:

- Provided signed, written informed consent.

- Diagnosed with primary open-angle glaucoma or ocular hypertension.

- 18 years of age and older.

- If a subject is a female of childbearing potential, she must utilize reliable
contraceptive throughout the study, and must have a negative urine pregnancy test
prior to enrollment into this study.

Exclusion Criteria:

- Females who are pregnant, nursing or planning a pregnancy, or females of childbearing
potential who are not using a reliable method of contraception.

- Presence of any abnormality or significant illness that could be expected to interfere
with the study.

We found this trial at

sites

David Shulman, MD P-A

999 East Basse Road
San Antonio, Texas 78209

from

San Antonio, TX